LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
4.820
+0.440 (10.05%)
At close: Oct 2, 2026, 4:00 PM EDT
4.770
-0.050 (-1.04%)
After-hours: Oct 2, 2026, 7:52 PM EDT
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $45.41 million as of October 2, 2026. Its market cap has increased by 174.15% in one year.
Market Cap
45.41M
Enterprise Value
-5.08M
1-Year Change
174.15%
Ranking
Category
Stock Price
$4.82
ChartMarket Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $45.41M, a decrease of -91.39%. That is a compound annual growth rate of -33.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 45.41M | 52.11% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 35.54M |
| Aligos Therapeutics | 35.53M |
| Immutep | 34.95M |
| Seres Therapeutics | 33.60M |
| NanoViricides | 33.31M |
| BeyondSpring | 32.45M |
| Quince Therapeutics | 32.13M |
| aTyr Pharma | 30.40M |